Effect of Adjunctive Estradiol on Schizophrenia Among Women of Childbearing Age
Authors:
Open Access
- 1 October 2019
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA Psychiatry
- Vol. 76 (10) , 1009-1017
Abstract
Although antipsychotic drugs are of value in reducing the symptoms of schizophrenia,1,2 mortality, hospitalizations, and suicide3 as well as treating agitation, hallucinations, and delusions, they do not help negative symptoms or cognitive impairments4 and cause significant adverse effects.4 New directions in treatment of schizophrenia are urgently needed, but as in other fields of medicine,5 many promising new directions for treatment have been reported, but not later replicated.6 Well-replicated sex differences in the age of onset and course of schizophrenia indicate that estradiol might influence the course of schizophrenia.7 Several randomized clinical trials have been conducted on the administration of oral estradiol to female patients with schizophrenia; most, but not all, trials reported a beneficial effect.8 Three studies on estradiol patches in women with schizophrenia have been published. An initial 4-week pilot study in 36 women showed a decrease in positive symptoms using 100-μg estradiol patches9; this study was followed by a larger (N = 102) 4-week study showing improvements in positive symptoms and general psychopathology with the use of 100-μg estradiol patches in women with schizophrenia.10 A larger 8-week study of 183 women of childbearing age administered 100-μg and 200-μg estradiol patches vs placebo and showed significant improvements in positive symptoms (effect size, 0.44), general psychopathology subscale, and total Positive and Negative Syndrome Scale (PANSS) scores, with the higher dose showing greater effects.11 All studies used add-on designs in which estradiol or placebo was added to an antipsychotic drug; estradiol doses above 200 μg have not been tested.Keywords
This publication has 28 references indexed in Scilit:
- Potential Contribution of Aromatase Inhibition to the Effects of Nicotine and Related Compounds on the BrainFrontiers in Pharmacology, 2012
- Estrogen Actions in the Brain and the Basis for Differential Action in Men and Women: A Case for Sex-Specific MedicinesPharmacological Reviews, 2010
- Nicotine Blocks Brain Estrogen Synthase (Aromatase): In Vivo Positron Emission Tomography Studies in Female BaboonsBiological Psychiatry, 2010
- SchizophreniaThe Lancet, 2009
- Association between medication and risk of suicide, attempted suicide and death in nationwide cohort of suicidal patients with schizophreniaPharmacoepidemiology and Drug Safety, 2008
- Estrogen, menstrual cycle phases, and psychopathology in women suffering from schizophreniaPsychological Medicine, 2007
- Contradicted and Initially Stronger Effects in Highly Cited Clinical ResearchJAMA, 2005
- A clinical trial of adjunctive oestrogen treatment in women with schizophreniaArchives of Women's Mental Health, 2002
- Association of Estrogen Levels With Neuropsychological Performance in Women With SchizophreniaAmerican Journal of Psychiatry, 2001
- A RATING SCALE FOR EXTRAPYRAMIDAL SIDE EFFECTSActa Psychiatrica Scandinavica, 1970